Literature DB >> 33686088

Bioinformatis analysis reveals possible molecular mechanism of PXR on regulating ulcerative colitis.

Hanze Guo1,2, Yan Chi3, Naiyu Chi4.   

Abstract

Inflammatory bowel disease (IBD) is a chronic, recurrent inflammatory disease of the gastrointestinal (GI) tract. Ulcerative colitis (UC) is a type of IBD. Pregnane X Receptor (PXR) is a member of the nuclear receptor superfamily. In order to deepen understanding and exploration of the molecular mechanism of regulation roles of PXR on UC, biological informatics analysis was performed. First, 878 overlapping differentially expressed genes (DEGs) between UC and normal samples were obtained from the Gene Expression Omnibus (GEO) database (GSE59071 and GSE38713) by using the "limma" R language package. Then WGCNA analysis was performed by 878 DEGs to obtain co-expression modules that were positively and negatively correlated with clinical traits. GSEA analysis of PXR results obtained the signal pathways enriched in the PXR high and low expression group and the active genes of each signal pathway. Then the association of PXR with genes that are both active in high expression group and negatively related to diseases (gene set 1), or both active in low expression group and negatively related to diseases (gene set 2) was analyzed by String database. Finally, carboxylesterase 2 (CES2), ATP binding cassette subfamily G member 2 (ABCG2), phosphoenolpyruvate carboxykinase (PCK1), PPARG coactivator 1 alpha (PPARGC1A), cytochrome P450 family 2 subfamily B member 6 (CYP2B6) from gene set 1 and C-X-C motif chemokine ligand 8 (CXCL8) from gene set 2 were screened out. After the above analysis and reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) verification, we speculated that PXR may exert a protective role on UC by promoting CES2, ABCG2, PCK1, PPARGC1A, CYP2B6 expression and inhibiting CXCL8 expression in their corresponding signal pathway in intestinal tissue.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33686088      PMCID: PMC7940411          DOI: 10.1038/s41598-021-83742-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  55 in total

1.  Circulating mitochondrial DAMPs cause inflammatory responses to injury.

Authors:  Qin Zhang; Mustafa Raoof; Yu Chen; Yuka Sumi; Tolga Sursal; Wolfgang Junger; Karim Brohi; Kiyoshi Itagaki; Carl J Hauser
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

2.  The null hypothesis of GSEA, and a novel statistical model for competitive gene set analysis.

Authors:  Birgit Debrabant
Journal:  Bioinformatics       Date:  2017-05-01       Impact factor: 6.937

3.  ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.

Authors:  Silvio Danese; Gionata Fiorino; Tim Raine; Marc Ferrante; Karen Kemp; Jaroslaw Kierkus; Peter L Lakatos; Gerassimos Mantzaris; Janneke van der Woude; Julian Panes; Laurent Peyrin-Biroulet
Journal:  J Crohns Colitis       Date:  2016-12-07       Impact factor: 9.071

4.  TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.

Authors:  Liping Su; Sam C Nalle; Le Shen; Emily S Turner; Gurminder Singh; Lydia A Breskin; Ekaterina A Khramtsova; Galina Khramtsova; Pei-Yun Tsai; Yang-Xin Fu; Clara Abraham; Jerrold R Turner
Journal:  Gastroenterology       Date:  2013-04-22       Impact factor: 22.682

5.  The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease.

Authors:  Megan M Dring; Carol A Goulding; Valerie I Trimble; Denise Keegan; Anthony W Ryan; Karen M Brophy; Claire M Smyth; P W Napoleon Keeling; Diarmuid O'Donoghue; Maria O'Sullivan; Colm O'Morain; Nasir Mahmud; Ann-Charlotte Wikström; Dermot Kelleher; Ross McManus
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

6.  STRING v10: protein-protein interaction networks, integrated over the tree of life.

Authors:  Damian Szklarczyk; Andrea Franceschini; Stefan Wyder; Kristoffer Forslund; Davide Heller; Jaime Huerta-Cepas; Milan Simonovic; Alexander Roth; Alberto Santos; Kalliopi P Tsafou; Michael Kuhn; Peer Bork; Lars J Jensen; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2014-10-28       Impact factor: 16.971

7.  CD36 deficiency impairs the small intestinal barrier and induces subclinical inflammation in mice.

Authors:  Vincenza Cifarelli; Stoyan Ivanov; Yan Xie; Ni-Huiping Son; Brian T Saunders; Terri A Pietka; Trevor M Shew; Jun Yoshino; Sinju Sundaresan; Nicholas O Davidson; Ira J Goldberg; Andrew E Gelman; Bernd H Zinselmeyer; Gwendalyn J Randolph; Nada A Abumrad
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-01

8.  Stromal miR-20a controls paracrine CXCL8 secretion in colitis and colon cancer.

Authors:  Steven A Signs; Robert C Fisher; Uyen Tran; Susmita Chakrabarti; Samaneh K Sarvestani; Shao Xiang; David Liska; Veronique Roche; Wei Lai; Haley R Gittleman; Oliver Wessely; Emina H Huang
Journal:  Oncotarget       Date:  2018-02-14

Review 9.  Nutritional Aspects in Inflammatory Bowel Diseases.

Authors:  Paola Balestrieri; Mentore Ribolsi; Michele Pier Luca Guarino; Sara Emerenziani; Annamaria Altomare; Michele Cicala
Journal:  Nutrients       Date:  2020-01-31       Impact factor: 5.717

Review 10.  A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Qingdong Guan
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

View more
  1 in total

1.  LncRNA-miRNA-mRNA Network Analysis Reveals the Potential Biomarkers in Crohn's Disease Rats Treated with Herb-Partitioned Moxibustion.

Authors:  Xue-Jun Wang; Xiao-Ying Li; Xiao-Cong Guo; Li Liu; You-You Jin; Yun-Qiong Lu; Yao-Jia-Ni Cao; Jun-Yi Long; Huan-Gan Wu; Dan Zhang; Guang Yang; Jue Hong; Yan-Ting Yang; Xiao-Peng Ma
Journal:  J Inflamm Res       Date:  2022-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.